Your browser doesn't support javascript.
loading
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial.
Chase, Dana M; Marín, Margarita Romeo; Backes, Floor; Han, Sileny; Graybill, Whitney; Mirza, Mansoor Raza; Pothuri, Bhavana; Mangili, Giorgia; O'Malley, David M; Berton, Dominique; Willmott, Lyndsay; Baumann, Klaus; Coleman, Robert L; Safra, Tamar; Heinzelmann-Schwarz, Viola; Lorusso, Domenica; Karl, Florian M; Woodward, Tatia; Monk, Bradley J; Gonzalez-Martin, Antonio.
Afiliação
  • Chase DM; Virginia G Piper Cancer Care Network, University of Arizona, Creighton University, Phoenix, AZ, USA. Electronic address: dana.chase@usoncology.com.
  • Marín MR; The Spanish Ovarian Cancer Research Group and Medical Oncology Department, Institut Català d'Oncologia, Badalona, Spain.
  • Backes F; The Ohio State University Wexner Medical Center, and James Cancer Hospital, Division of Gynecologic Oncology, Columbus, OH, USA.
  • Han S; University Hospitals Leuven, Belgium and Luxembourg Gynaecological Oncology Group and Department of Gynaecology and Obstetrics, Leuven, Belgium.
  • Graybill W; Medical University of South Carolina, Gynecologic Oncology Group and Department of Gynecologic Oncology, Charleston, SC, USA.
  • Mirza MR; Nordic Society of Gynaecological Oncology-Clinical Trial Unit and Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Pothuri B; New York University Grossman School of Medicine, New York University Langone Health, Laura and Isaac Perlmutter Cancer Center, Gynecologic Oncology Group and Department of Obstetrics/Gynecology and Medicine, New York, NY, USA.
  • Mangili G; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies and Scientific Institute for Research, Hospitalization and Healthcare Ospedale San Raffaele, Milan, Italy.
  • O'Malley DM; The Ohio State University Wexner Medical Center, and James Cancer Hospital, Division of Gynecologic Oncology, Columbus, OH, USA.
  • Berton D; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire et du Sein and Institut de Cancérologie de l'Ouest, Nantes, France.
  • Willmott L; Gynecologic Oncology Group and Arizona Oncology (US Oncology Network), University of Arizona, Creighton University, Phoenix, AZ, USA.
  • Baumann K; Arbeitsgemeinschaft Gynäkologische Onkologie and Klinikum der Stadt Ludwigshafen, Ludwigshafen Am Rhein, Germany.
  • Coleman RL; US Oncology Research and Gynecologic Oncology Group Foundation, The Woodlands, TX, USA.
  • Safra T; Israeli Society of Gynecologic Oncology and Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv, Israel.
  • Heinzelmann-Schwarz V; Swiss Group for Clinical Cancer Research and University Hospital Basel, Basel, Switzerland.
  • Lorusso D; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies and Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Karl FM; GSK, Munich, Germany.
  • Woodward T; GSK, Philadelphia, PA, USA.
  • Monk BJ; Gynecologic Oncology Group and HonorHealth Research Institute, University of Arizona, Creighton University, Phoenix, AZ, USA.
  • Gonzalez-Martin A; The Spanish Ovarian Cancer Research Group, Medical Oncology Department Clínica Universidad de Navarra, Madrid, and Program in Solid Tumours, Centre for Applied Medical Research, Pamplona, Spain.
Gynecol Oncol ; 166(3): 494-502, 2022 09.
Article em En | MEDLINE | ID: mdl-35851489
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Qualidade de Vida Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Qualidade de Vida Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article